Nine Monthly Results Results Snapshot
Figures in Cr
No Consolidated Results Declared by Maitreya Medica.
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Mar 2024 is -1.80% vs 0.47% in Mar 2024
Consolidate Net Profit
YoY Growth in nine months ended Mar 2024 is -285.00% vs -85.51% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Mar 2024 is -95.11% vs -68.18% in Mar 2024
Interest
YoY Growth in nine months ended Mar 2024 is -2.60% vs 48.08% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Mar 2024 has fallen from Mar 2024
Compare Nine Monthly Results Of Maitreya Medica. With
Figures in Cr
No Consolidated Results Declared by Maitreya Medica.
Nine Monthly - Net Sales
Net Sales 36.02 Cr
in Mar 2024Figures in Cr
YoY Growth in nine months ended Mar 2024 is -1.80% vs 0.47% in Mar 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit -1.11 Cr
in Mar 2024Figures in Cr
YoY Growth in nine months ended Mar 2024 is -285.00% vs -85.51% in Mar 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.11 Cr
in Mar 2024Figures in Cr
YoY Growth in nine months ended Mar 2024 is -95.11% vs -68.18% in Mar 2024
Nine Monthly - Interest
Interest 0.75 Cr
in Mar 2024Figures in Cr
YoY Growth in nine months ended Mar 2024 is -2.60% vs 48.08% in Mar 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.31%
in Mar 2024Figures in %
YoY Growth in nine months ended Mar 2024 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
